AI brief of an SEC Form 8-K · Quaker Chemical (KWR)

Quaker Houghton Q2 net loss of $66.6 million on $88.8 million impairment; sales up 4%

Mixed Impact 4 of 5 earnings Written later

Quaker Houghton reported second-quarter 2025 net sales of $483.4 million, up 4% from a year earlier, but posted a net loss of $66.6 million, or $3.78 per diluted share, driven by an $88.8 million non-cash goodwill impairment tied to its EMEA segment. Non-GAAP earnings per diluted share fell to $1.71 from $2.13, and management expects a stronger second half with full-year 2025 revenue and earnings in the range of 2024.

Key points

  • Net sales rose 4% to $483.4 million from $463.6 million, with organic sales volumes up 2%.
  • Net loss of $66.6 million, or $3.78 per diluted share, compared with net income of $34.9 million a year earlier.
  • Non-GAAP earnings per diluted share were $1.71 versus $2.13; adjusted EBITDA was $75.5 million, down about 10%.
  • Management expects full-year 2025 revenue and earnings in the range of 2024 and about $20 million of run-rate cost savings by the end of 2026.

The filing

CompanyQuaker Chemical (KWR)
Form8-K, current report
Filed with the SECJul 31, 2025, 4:35 PM ET
Accession number0000081362-25-000118

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.